How a specific molecule affects immune cells in allergic asthma
PGI2 regulation of CD4+ Th2 metabolism in allergic airway inflammation
This study is looking at how a substance called PGI2 affects certain immune cells involved in allergic asthma, with the hope of finding new ways to improve treatments for people who suffer from this condition.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Veterans Health Administration NIH-funded |
| Lab location | 1 site (Nashville, United States) |
| Project ID | NIH-10867329 on NIH RePORTER |
What this research studies
This research investigates the role of prostaglandin I2 (PGI2) in regulating the metabolism of CD4 T helper 2 (Th2) cells, which are crucial in allergic asthma. The study aims to understand how PGI2 influences the inflammatory response in the lungs by inhibiting glycolysis in these immune cells. By examining the mechanisms behind PGI2's effects, the research seeks to uncover new insights into allergic airway inflammation and potential therapeutic targets. Patients with allergic asthma may benefit from findings that could lead to improved treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with allergic asthma or related allergic conditions.
Not a fit: Patients without allergic asthma or those with non-allergic respiratory conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for managing allergic asthma and reducing inflammation.
How similar studies have performed: Previous research has shown promising results regarding the role of metabolic pathways in immune responses, suggesting that this approach could yield significant insights.
Where this research is happening
Nashville, United States
- Veterans Health Administration — Nashville, United States (Active)
Researchers
- Principal investigator: Peebles, Ray Stokes — Veterans Health Administration
- Study coordinator: Peebles, Ray Stokes
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.